Retinal involvement in patients with juvenile dermatomyositis.
The authors describe the clinical presentations and ophthalmic findings of two patients with juvenile dermatomyositis. The results of their dilated eye examinations proved to influence the treatment of the disease process because retinal pathology was used as a factor to escalate the degree of anti-inflammatory therapy. Therefore, an initial ophthalmic examination may be considered in patients with new-onset juvenile dermatomyositis.
Brusco
Michael
M
University of Kansas Medical Center, Department of Ophthalmology, Kansas City, Kansas, USA. brusco@post.harvard.edu
Hug
Denise
D
Lasky
Andrew
A
Hoeltzel
Mark
M
D000293:Adolescent; D002648:Child; D003131:Combined Modality Therapy; D003882:Dermatomyositis / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D020551:Pulse Therapy, Drug; D012164:Retinal Diseases / Q000175:diagnosis* / Q000188:drug therapy; D014786:Vision Disorders / Q000175:diagnosis; D014792:Visual Acuity
D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D008775:Methylprednisolone